English
Home > Products > 23356-96-9

China 23356-96-9 Factory

With our leading technology as well as our spirit of innovation,mutual cooperation, benefits and development, we will build a prosperous future together with your esteemed company for 23356-96-9,CAS NO 23356-96-9,L-(+)-Prolinol, Our final target is "To consider the most effective, To be the Best". Please experience cost-free to call with us if you have any prerequisites.
23356-96-9, We are sincerely looking forward to cooperate with customers all over the world. We believe we can satisfy you with our high-quality goods and perfect service . We also warmly welcome customers to visit our company and purchase our solutions.

Related Products

Hot Products

  • Azilsartan kamedoxomil

    Azilsartan kamedoxomil

    Product Name:Azilsartan kamedoxomil
    Molecular Formula:C30H25KN4O8
    Molecular Weight:608.65
    CAS Registry Number;863031-24-7
  • Cinepazide maleate

    Cinepazide maleate

    Product Name:Cinepazide maleate
    Molecular Formula:C26H35N3O9
    Molecular Weight;533.57
    CAS Registry Number;26328-04-1
  • Oclacitinib maleate

    Oclacitinib maleate

    Product Name:Oclacitinib maleate
    Molecular Formula:C19H27N5O6S
    Molecular Weight;453.51258
    CAS Registry Number;1640292-55-2
  • 7,10-Dimethoxy-10-DAB III

    7,10-Dimethoxy-10-DAB III

    Product Name:7,10-Dimethoxy-10-DAB III
    Molecular Formula:C31H40O10
    Molecular Weight:572.64
    CAS Registry Number:183133-94-0
  • Miglitol Tablets

    Miglitol Tablets

    Product Name:Miglitol Tablets
    Dosage:50mg
    Application:Digestion
  • Pinacolborane

    Pinacolborane

    Product Name:Pinacolborane
    Molecular Formula:C6H13BO2
    Molecular Weight:127.98
    CAS Registry Number:25015-63-8
  • Related Blog
  • Reviews

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Related Search

CAS NO 23356-96-9

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept